P2RX7：一种在炎症和癌症中具有双重特性的受体。
P2RX7: A receptor with a split personality in inflammation and cancer.
作者信息
Di Virgilio Francesco
机构信息
Department of Morphology; Surgery and Experimental Medicine; Section of Pathology; Oncology and Experimental Biology; University of Ferrara ; Ferrara, Italy.
出版信息
Mol Cell Oncol. 2015 Feb 3;3(2):e1010937. doi: 10.1080/23723556.2015.1010937. eCollection 2016 Mar.
Abstract
P2X7 (also known as P2RX7) is a plasma membrane receptor for extracellular ATP that is expressed at a high level by immune and tumor cells. Previous data showed that increased P2rx7 expression by tumor cells accelerates tumor progression. We have now looked at the other side of the relationship by investigating the effect of a lack of host P2rx7 expression on tumor growth. Our novel observations highlight a surprising role of host P2rx7 in restraining tumor progression.
摘要
P2X7（也称为P2RX7）是一种细胞外ATP的质膜受体，在免疫细胞和肿瘤细胞中高水平表达。先前的数据表明，肿瘤细胞中P2rx7表达增加会加速肿瘤进展。我们现在通过研究宿主缺乏P2rx7表达对肿瘤生长的影响，来审视这种关系的另一面。我们的新发现突出了宿主P2rx7在抑制肿瘤进展中令人惊讶的作用。
相似文献
1
P2RX7: A receptor with a split personality in inflammation and cancer.P2RX7：一种在炎症和癌症中具有双重特性的受体。
Mol Cell Oncol. 2015 Feb 3;3(2):e1010937. doi: 10.1080/23723556.2015.1010937. eCollection 2016 Mar.
2
Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer.嘌呤能 P2RX7 受体的遗传和药理学失活可抑制炎症，但会增加结肠炎相关癌症小鼠模型中的肿瘤发生率。
Cancer Res. 2015 Mar 1;75(5):835-45. doi: 10.1158/0008-5472.CAN-14-1778. Epub 2015 Jan 6.
3
P2RX7 at the Host-Pathogen Interface of Infectious Diseases.P2RX7 在感染性疾病的宿主-病原体界面上的作用。
Microbiol Mol Biol Rev. 2021 Jan 13;85(1). doi: 10.1128/MMBR.00055-20. Print 2021 Feb 17.
4
The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain.三磷酸腺苷门控型 P2X7 受体介导的谷氨酸释放在神经病理性疼痛动物模型中的作用。
Brain Res Bull. 2013 Apr;93:80-5. doi: 10.1016/j.brainresbull.2012.09.016. Epub 2012 Oct 6.
5
Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator.体内评估P2RX7免疫调节剂激活情况的方案
Biol Proced Online. 2023 Jan 4;25(1):1. doi: 10.1186/s12575-022-00188-6.
6
P2X7 Receptors Drive Poly(I:C) Induced Autism-like Behavior in Mice.P2X7 受体驱动聚肌苷酸-聚胞苷酸诱导的小鼠自闭症样行为。
J Neurosci. 2019 Mar 27;39(13):2542-2561. doi: 10.1523/JNEUROSCI.1895-18.2019. Epub 2019 Jan 25.
7
P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?P2RX7嘌呤受体作为治疗靶点——卷土重来？
Front Chem. 2018 Jun 28;6:248. doi: 10.3389/fchem.2018.00248. eCollection 2018.
8
Epigenetic alteration of the purinergic type 7 receptor in salivary epithelial cells.唾液腺上皮细胞中嘌呤能7型受体的表观遗传改变。
Biochem Biophys Res Commun. 2015 Oct 30;466(4):704-10. doi: 10.1016/j.bbrc.2015.09.095. Epub 2015 Sep 21.
9
Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis.家族性多发性硬化症中的嘌呤能受体P2RX4和P2RX7
Hum Mutat. 2017 Jun;38(6):736-744. doi: 10.1002/humu.23218. Epub 2017 Apr 13.
10
..
Sci Immunol. 2018 Dec 14;3(30). doi: 10.1126/sciimmunol.aau1022.
引用本文的文献
1
Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.肺腺癌中预后免疫细胞动态平衡特征的鉴定和分析。
Clin Respir J. 2024 May;18(5):e13755. doi: 10.1111/crj.13755.
2
Ion channel P2X7 receptor in the progression of cancer.离子通道P2X7受体在癌症进展中的作用
Front Oncol. 2024 Jan 11;13:1297775. doi: 10.3389/fonc.2023.1297775. eCollection 2023.
3
Purine and purinergic receptors in health and disease.健康与疾病中的嘌呤及嘌呤能受体
MedComm (2020). 2023 Sep 7;4(5):e359. doi: 10.1002/mco2.359. eCollection 2023 Oct.
4
The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies.嘌呤能 P2X7 受体在肌肉疾病发病机制和治疗中的作用。
Int J Mol Sci. 2023 May 29;24(11):9434. doi: 10.3390/ijms24119434.
5
Primary mouse myoblast metabotropic purinoceptor profiles and calcium signalling differ with their muscle origin and are altered in mdx dystrophinopathy.原代鼠肌母细胞代谢型嘌呤能受体谱及其钙信号转导随其肌肉起源而不同，并在 mdx 肌营养不良症中发生改变。
Sci Rep. 2023 Jun 8;13(1):9333. doi: 10.1038/s41598-023-36545-y.
6
A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients.一个功能丧失的多态性降低了头颈部癌患者的治疗效果。
Oncoimmunology. 2022 Apr 17;11(1):2059878. doi: 10.1080/2162402X.2022.2059878. eCollection 2022.
7
Unraveling the Relevance of ARL GTPases in Cutaneous Melanoma Prognosis through Integrated Bioinformatics Analysis.通过综合生物信息学分析揭示 ARL GTPases 在皮肤黑色素瘤预后中的相关性。
Int J Mol Sci. 2021 Aug 26;22(17):9260. doi: 10.3390/ijms22179260.
8
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy.一种小分子P2RX7激活剂可促进抗肿瘤免疫反应并使肺肿瘤对免疫疗法敏感。
Nat Commun. 2021 Jan 28;12(1):653. doi: 10.1038/s41467-021-20912-2.
9
Purinergic signaling in peripheral nervous system glial cells.嘌呤能信号在周围神经系统神经胶质细胞中的作用。
Glia. 2021 Aug;69(8):1837-1851. doi: 10.1002/glia.23969. Epub 2021 Jan 28.
10
Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts.人源 P2X7 受体导致 RPMI-8226 骨髓瘤细胞周期停滞，改变其与成骨细胞和破骨细胞的相互作用。
Cells. 2020 Oct 22;9(11):2341. doi: 10.3390/cells9112341.
本文引用的文献
1
Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer.嘌呤能 P2RX7 受体的遗传和药理学失活可抑制炎症，但会增加结肠炎相关癌症小鼠模型中的肿瘤发生率。
Cancer Res. 2015 Mar 1;75(5):835-45. doi: 10.1158/0008-5472.CAN-14-1778. Epub 2015 Jan 6.
2
Accelerated tumor progression in mice lacking the ATP receptor P2X7.缺乏 ATP 受体 P2X7 的小鼠中肿瘤的加速进展。
Cancer Res. 2015 Feb 15;75(4):635-44. doi: 10.1158/0008-5472.CAN-14-1259. Epub 2014 Dec 26.
3
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.ATP/P2X7轴调节神经母细胞瘤微环境中髓源性抑制细胞的功能。
Cell Death Dis. 2014 Mar 20;5(3):e1135. doi: 10.1038/cddis.2014.109.
4
Purinergic signalling: from discovery to current developments.嘌呤能信号转导：从发现到当前进展。
Exp Physiol. 2014 Jan;99(1):16-34. doi: 10.1113/expphysiol.2013.071951. Epub 2013 Sep 27.
5
Purines, purinergic receptors, and cancer.嘌呤、嘌呤能受体与癌症。
Cancer Res. 2012 Nov 1;72(21):5441-7. doi: 10.1158/0008-5472.CAN-12-1600. Epub 2012 Oct 22.
6
Expression of P2X7 receptor increases in vivo tumor growth.P2X7 受体的表达增加了体内肿瘤的生长。
Cancer Res. 2012 Jun 15;72(12):2957-69. doi: 10.1158/0008-5472.CAN-11-1947. Epub 2012 Apr 13.
7
P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness.P2X（7）受体的激活增强了 SK3 通道和半胱氨酸组织蛋白酶依赖性癌细胞的侵袭性。
Oncogene. 2011 May 5;30(18):2108-22. doi: 10.1038/onc.2010.593. Epub 2011 Jan 17.
8
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.移植物抗宿主病是由细胞外 ATP 通过激活 P2X7R 而增强的。
Nat Med. 2010 Dec;16(12):1434-8. doi: 10.1038/nm.2242. Epub 2010 Nov 21.
9
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP.杰基尔博士/海德先生：细胞外ATP的双重作用。
J Auton Nerv Syst. 2000 Jul 3;81(1-3):59-63. doi: 10.1016/s0165-1838(00)00114-4.
Zotero 插件